Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias R Lemke

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|October 13, 2006
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disordersMarkus Jäger, Michael Riedel, Thomas Messer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 14, 2007
Prediction of symptom remission in schizophrenia during inpatient treatmentMarkus Jäger, Michael Riedel, Max Schmauss, et al.
Schizophrenia Research|June 30, 2009
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disordersRebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, et al.
Schizophrenia Research|June 5, 2012
Response trajectories in "real-world" naturalistically treated schizophrenia patientsRebecca Schennach, Sebastian Meyer, Florian Seemüller, et al.
Journal of Psychiatric Research|June 10, 2009
Attitude towards adherence in patients with schizophrenia at dischargeRebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 13, 2010
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?Rebecca Schennach-Wolff, Markus Jäger, Michael Obermeier, et al.
Journal of Psychiatric Research|August 25, 2011
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorderRebecca Schennach-Wolff, Sebastian Meyer, Florian Seemüller, et al.
Psychiatric Services (Washington, D.C.)|January 10, 2012
Predictors of relapse in the year after hospital discharge among patients with schizophreniaRebecca Schennach, Michael Obermeier, Sebastian Meyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 28, 2014
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic studyRebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Archives of Psychiatry and Clinical Neuroscience|October 13, 2006
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disordersMarkus Jäger, Michael Riedel, Thomas Messer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 14, 2007
Prediction of symptom remission in schizophrenia during inpatient treatmentMarkus Jäger, Michael Riedel, Max Schmauss, et al.
Schizophrenia Research|June 30, 2009
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disordersRebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, et al.
Schizophrenia Research|June 5, 2012
Response trajectories in "real-world" naturalistically treated schizophrenia patientsRebecca Schennach, Sebastian Meyer, Florian Seemüller, et al.
Journal of Psychiatric Research|June 10, 2009
Attitude towards adherence in patients with schizophrenia at dischargeRebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 13, 2010
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?Rebecca Schennach-Wolff, Markus Jäger, Michael Obermeier, et al.
Journal of Psychiatric Research|August 25, 2011
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorderRebecca Schennach-Wolff, Sebastian Meyer, Florian Seemüller, et al.
Psychiatric Services (Washington, D.C.)|January 10, 2012
Predictors of relapse in the year after hospital discharge among patients with schizophreniaRebecca Schennach, Michael Obermeier, Sebastian Meyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 28, 2014
What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trialRebecca Schennach, Michael Riedel, Michael Obermeier, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic studyRebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.
Pageof 3